Current Status of the Molecular Characterization of the Ovarian Cancer Antigen CA125 and Implications for Its Use in Clinical Screening

This publication has 55 references indexed in Scilit:

• CA125 Phosphorylation Is Associated with Its Secretion from the WISH Human Amnion Cell Line
  Tumor Biology, 1997
• Human Peritoneal Mesothelial Cells Are More Potent Than Ovarian Cancer Cells in Producing Tumor Marker CA-125
  Gynecologic Oncology, 1996
• Immunologic characterization of tumor markers in human ovarian cancer cell lines
  Journal of the Society for Gynecologic Investigation, 1996
• Serum tumor marker immunoassays in gynecologic oncology: Establishment of reference values
  American Journal of Obstetrics and Gynecology, 1996
• Immunohistochemical Characterization of 22 Monoclonal Antibodies against the CA125 Antigen: 2nd Report from the ISOBM TD-1 Workshop
  Tumor Biology, 1996
• Purification and Characterization of the CA 125 Tumor-Associated Antigen from Human Ascites
  Tumor Biology, 1993
• Tumour necrosis factor and cancer
  Progress in Growth Factor Research, 1992
• Characterization of the CA125 Antigen Secreted from a Newly Established Human Ovarian Cancer Cell Line (SHIN‐3)
  Acta Pathologica Japonica, 1989
• CA 125 (ovarian tumour-associated antigen) in ascitic liver diseases
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1986
• A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer
  New England Journal of Medicine, 1983